Keflex is a brand of cephalexin, a first-generation cephalosporin used for susceptible skin, urinary, throat and other bacterial infections; it is primarily active against common gram-positive organisms with limited gram-negative coverage, so culture results, allergy history and renal function help determine whether it is the right oral beta-lactam.
What to Know
- Keflex and generic cephalexin contain the same active antibiotic, with differences mainly in manufacturer, inactive ingredients and presentation.
- For uncomplicated cellulitis, cephalexin is often selected when streptococci and methicillin-susceptible Staphylococcus aureus are the likely pathogens.
- It does not reliably treat MRSA, Pseudomonas or many beta-lactamase-producing gram-negative organisms.
- Because cephalexin is renally eliminated, significant kidney impairment can require a longer interval or lower total daily dose.
Keflex — Cephalexin Remains One of the Most Familiar Oral Cephalosporins
Keflex is a brand name for cephalexin, a first-generation cephalosporin antibiotic that has been used for decades in skin, throat, respiratory and urinary bacterial infections when the organism is susceptible. Its clinical appeal comes from predictable oral absorption, extensive experience and useful activity against many streptococci and methicillin-susceptible staphylococci, along with selected gram-negative organisms. That range is broad enough to make cephalexin common in outpatient medicine but not broad enough to make it a reasonable choice for every infection that produces redness, pain or fever.
This page includes multiple cephalexin strengths and package quantities under the Keflex name. The manufacturer or supply field shown on the current listing is Market supply varies, and the current starting price is $32.99. A low-priced large package should not be treated as a reason to buy extra antibiotics, because the correct quantity should follow the prescribed course and the diagnosis rather than the economics of a larger bottle.
Skin Infections Are a Common Setting, but the Organism Still Matters
Cephalexin is frequently selected for uncomplicated cellulitis and other skin infections where streptococci or methicillin-susceptible Staphylococcus aureus are likely. It does not reliably cover methicillin-resistant S. aureus, and an abscess may require drainage rather than a stronger or longer antibiotic course. This distinction explains why two red, painful skin lesions can receive very different treatment even when they look similar to a patient.
For streptococcal pharyngitis, cephalexin can be an alternative in selected patients who cannot use first-line penicillin therapy, although the nature of a previous penicillin allergy matters. Respiratory symptoms caused by viruses should not be treated with cephalexin simply because the sputum is colored or the illness has lasted several days. The antibiotic has no activity against influenza, common cold viruses or most other viral respiratory infections.
Penicillin Allergy Requires More Detail Than a Yes-or-No Checkbox
Cephalosporins and penicillins share beta-lactam structural features, so cross-reactivity is possible, although the actual risk depends on the type of prior reaction and structural similarity between drugs. A vague childhood rash is different from documented anaphylaxis, facial swelling or a severe delayed skin reaction. The current DailyMed cephalexin labeling advises clinicians to ask about previous hypersensitivity to cephalexin, cephalosporins, penicillins and other drugs before treatment.
Patients with a history of Stevens-Johnson syndrome, toxic epidermal necrolysis or another severe immune-mediated reaction to a beta-lactam should not reduce that history to “I had a rash.” Serious reactions can change which related antibiotics are considered. Conversely, many people who carry a penicillin-allergy label are not truly allergic, and formal allergy evaluation can sometimes expand future antibiotic options.
- Describe the exact previous penicillin or cephalosporin reaction rather than only reporting an allergy label.
- Seek urgent care for facial swelling, breathing difficulty, blistering rash or signs of anaphylaxis.
- Report persistent severe diarrhea during or after the course because C. difficile can occur after antibiotic use.
- Use the prescribed duration and avoid storing leftover capsules for a future infection.
Kidney Function Can Change the Dose and Dosing Interval
Cephalexin is eliminated substantially through the kidneys, so reduced renal function can increase drug exposure and require adjustment. This becomes particularly relevant in older adults, people with chronic kidney disease and patients taking other medicines that affect renal function. The presence of kidney disease does not automatically exclude cephalexin, but a standard schedule copied from a previous prescription may not be appropriate.
When renal function is significantly impaired, accumulation can increase the likelihood of adverse effects, including neurologic toxicity in extreme cases. A prescriber may use estimated kidney function to select an interval and total daily exposure rather than relying on the strength printed on the box alone.
Diarrhea Has a Wide Range of Meanings During Antibiotic Therapy
Mild loose stools can occur with cephalexin because the antibiotic changes intestinal flora. More severe or persistent diarrhea, particularly with abdominal pain, fever, dehydration or blood, raises concern for Clostridioides difficile infection, which has been reported with nearly all antibacterial agents. Symptoms can begin during the course or after the antibiotic has been completed, so a patient should not dismiss a significant late-onset episode simply because the cephalexin bottle is empty.
Anti-diarrheal medicines are not always appropriate when C. difficile is possible because slowing intestinal movement can complicate management. Medical assessment is more important than treating every antibiotic-associated stool change the same way.
Keflex and Generic Cephalexin in Mexico
Keflex is the familiar brand name, but generic cephalexin is produced by many manufacturers. Mexican pharmacies may list the active ingredient in Spanish as cefalexina, and packaging can differ substantially from products sold in the United States. Matching should focus on cephalexin, the prescribed strength, capsule or tablet form, manufacturer or authorization holder, lot and expiration date.
Brand preference can be reasonable when a patient has a specific history with one product, yet price differences should not be interpreted as differences in antibacterial strength when both medicines are properly authorized and contain the same labeled active ingredient. A culture showing resistance to cephalexin is not corrected by paying more for the original brand.
Antibiotic Stewardship Is Particularly Relevant to Familiar Drugs
Cephalexin is easy to recognize and usually inexpensive, which can encourage casual reuse. That is exactly why stewardship matters. A household may have leftover capsules after an interrupted course, but using them for a new sore throat, dental problem or skin lesion can delay the correct diagnosis and expose bacteria to an incomplete regimen. The value of cephalexin is preserved when it is used for infections that are likely to respond and for the duration appropriate to that infection.
Culture and susceptibility testing can narrow the decision after recurrent infection, previous treatment failure or complicated disease. In routine uncomplicated cases, clinicians often choose empirically based on the likely organism and local patterns, then reassess if the expected response does not occur.
Ordering From Mexico Does Not Change the Clinical Rules
Customers ordering cephalexin internationally should keep the prescription, original labeled package and invoice or pharmacy documentation. Destination-country customs rules can apply even when the medication is legally dispensed in Mexico. A personal-use shipment should be represented accurately and should not be enlarged simply to obtain a lower unit price.
The same discipline applies to treatment. A medicine that is inexpensive and widely available is still prescription antibacterial therapy, and worsening infection, fever, spreading redness or lack of improvement may require reassessment rather than another package. The goal is to treat the organism and clinical problem effectively, not merely to complete a transaction for a familiar antibiotic.
Dental Prescriptions Illustrate Why Source Control Still Comes First
Cephalexin is sometimes prescribed for dental infections, but antibiotics cannot remove a necrotic tooth, drain a mature abscess or correct another structural dental source. Temporary improvement can create the impression that the problem has been cured while the source remains. Persistent facial swelling, difficulty swallowing or spreading infection requires dental or emergency assessment rather than repeated courses from leftover capsules.
The same principle applies to infected wounds. Cleaning, drainage and management of foreign material can be more important than changing from one cephalosporin to another. Antibiotics work best when the non-pharmacologic part of infection control has also been addressed.
Culture After Failure Can Prevent Endless Empiric Switching
If an apparently appropriate cephalexin course fails, repeating it at a higher quantity is usually less informative than reassessing the diagnosis and obtaining culture material when possible. Treatment failure can reflect MRSA, an abscess, poor adherence, noninfectious inflammation or an organism outside cephalexin’s spectrum. The next step should answer that question rather than simply move to a broader drug without evidence.
Cephalexin can also alter results of some laboratory tests, including certain urine glucose methods and the direct Coombs test. These effects are not usually a reason to avoid treatment, but they illustrate why the laboratory and clinician should know the current antibiotic list when an unexpected result appears during a course.
